Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Shareholders Equity (Quarterly): 108.55M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 108.55M |
March 31, 2024 | -396.16M |
December 31, 2023 | -386.32M |
September 30, 2023 | -438.80M |
June 30, 2023 | -333.12M |
March 31, 2023 | -229.02M |
December 31, 2022 | -107.90M |
September 30, 2022 | -15.98M |
June 30, 2022 | 111.41M |
March 31, 2022 | 116.26M |
December 31, 2021 | 243.86M |
September 30, 2021 | 249.02M |
June 30, 2021 | 16.49M |
March 31, 2021 | 67.85M |
December 31, 2020 | 113.38M |
September 30, 2020 | 149.60M |
June 30, 2020 | -78.08M |
March 31, 2020 | -45.71M |
December 31, 2019 | -10.94M |
September 30, 2019 | -19.87M |
June 30, 2019 | -4.896M |
March 31, 2019 | 3.372M |
December 31, 2018 | 25.93M |
September 30, 2018 | 52.07M |
June 30, 2018 | 75.17M |
Date | Value |
---|---|
March 31, 2018 | 99.60M |
December 31, 2017 | 109.84M |
September 30, 2017 | 147.04M |
June 30, 2017 | 175.00M |
March 31, 2017 | 95.38M |
December 31, 2016 | 94.36M |
September 30, 2016 | 83.25M |
June 30, 2016 | 48.75M |
March 31, 2016 | 57.91M |
December 31, 2015 | 68.59M |
September 30, 2015 | 67.30M |
June 30, 2015 | 74.86M |
March 31, 2015 | 84.15M |
December 31, 2014 | 92.06M |
September 30, 2014 | 73.63M |
June 30, 2014 | 78.70M |
March 31, 2014 | 86.18M |
December 31, 2013 | 54.44M |
September 30, 2013 | 39.75M |
June 30, 2013 | 51.99M |
March 31, 2013 | 58.43M |
December 31, 2012 | 70.08M |
September 30, 2012 | 80.60M |
June 30, 2012 | 89.98M |
March 31, 2012 | 42.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-438.80M
Minimum
Sep 2023
249.02M
Maximum
Sep 2021
-45.56M
Average
-10.94M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 32.35M |
Biomarin Pharmaceutical Inc | 5.413B |
Catalyst Pharmaceuticals Inc | 608.66M |
Sarepta Therapeutics Inc | 1.077B |
Ocugen Inc | 16.93M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.524B |
Total Liabilities (Quarterly) | 1.415B |
Debt to Equity Ratio | 6.034 |
Current Ratio | 10.39 |
Net Debt Paydown Yield | -0.14% |